NCT05240482 is a NA clinical trial of ST36 acupuncture in Postoperative Nausea and Vomiting, sponsored by The Second Hospital of Anhui Medical University.

Who is sponsoring NCT05240482?

NCT05240482 is sponsored by The Second Hospital of Anhui Medical University.

What drugs are being tested in NCT05240482?

Interventions in NCT05240482: ST36 acupuncture.

What condition does NCT05240482 study?

NCT05240482 studies Postoperative Nausea and Vomiting.

Is NCT05240482 still recruiting?

NCT05240482 is currently completed. Last updated 15 July 2022.

Last reviewed 2022-07-15 · How we verify

NCT05240482

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

ST36 Acupoint Injection With Anisodamine for Postoperative Nausea and Vomiting

Completed NA Last updated 15 July 2022

What this trial tests

NA trial testing ST36 acupuncture in Postoperative Nausea and Vomiting in 90 participants. Completed in 6 July 2022.

Timeline

20 February 2022

Primary endpoint
10 May 2022

6 July 2022

Quick facts

Lead sponsor	The Second Hospital of Anhui Medical University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	quadruple
Primary purpose	prevention
Enrollment	90
Start date	20 February 2022
Primary completion	10 May 2022
Estimated completion	6 July 2022
Sites	1 location across China

Drugs / interventions tested

ST36 acupuncture

Conditions studied

Postoperative Nausea and Vomiting — all drugs for Postoperative Nausea and Vomiting →

Sponsor

The Second Hospital of Anhui Medical University

Who can join

Adults 18 to 65, female only, with Postoperative Nausea and Vomiting. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Postoperative nausea and vomiting (PONV) is particularly distressing although it is not a fatal postoperative complication. Numbers of studies have been focused on identifying risk factors and therapies of PONV. Unfortunately, there' no consistent comments for PONV prevention in women after laparoscopic sleeve gastrectomy. Notably, Zusanli (ST36) acupoint and anisodamine have been evidenced to treat various gastrointestinal conditions. The primary outcome of this study was to evaluate the impact of anisodamine injection in ST36 on PONV in women following bariatric surgery.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

ST36 acupoint injection with anisodamine for postoperative nausea and vomiting in female patients after bariatric surgery: a prospective, randomized controlled trial.
Xue Q, Xing Q, Dong L, Guo M, et al · · 2023 · cited 6× · PMID 37095234 · DOI 10.1007/s00464-023-10037-6

Verify or expand the search:

Other The Second Hospital of Anhui Medical University trials

Trials by the same sponsor.

NCT07533773 — Investigating Functional Changes in the Frontotemporal Cortex of Patients With Major Depressive Disorder Following Elect · NA · not yet recruiting
NCT07500064 — Transcranial Direct Current Stimulation for Depression · NA · not yet recruiting
NCT07373132 — Effects of Aromatherapy on Sleep Quality in Hospitalized Elderly Female Patients With Insomnia · NA · not yet recruiting
NCT07185022 — Intra-arterial Thrombolysis for Acute Ischemic Stroke With Medium Vessel Occlusion · NA · recruiting
NCT07023679 — Stellate Ganglion Morphine Infiltration on Myocardial I/R Injury · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05240482 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by The Second Hospital of Anhui Medical University
Last refreshed: 15 July 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05240482.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing